Welcome Message

Target Audience:

• Pharmaceutical Scientists and Researchers
• Chemical Engineers
• Pharmacists and Pharmacy Technicians
• Regulatory Affairs Professionals
• Quality Control/Assurance Personnel
• Academic Researchers
• Industry Consultants and Contract Research Organizations
• Medical Professionals
• Investors and Business Executives
• Pharmacy Students 

About Conference

Drug Formulation Bioavailability 2024 conference stands as a pivotal event, bringing together professionals, researchers, and experts dedicated to advancing the field of pharmaceutical formulation and bioavailability. This gathering serves as a dynamic hub for the exchange of knowledge, facilitation of networking opportunities, and cultivation of collaborations among individuals and organizations committed to exploring, innovating, and ensuring the efficacy and accessibility of pharmaceutical products. Scientists and experts in pharmaceutical sciences and related disciplines play a crucial role in driving forward our understanding of drug formulation and bioavailability, pioneering new techniques, and championing sustainable practices. Through the Drug Formulation Bioavailability 2024 conference, participants act as catalysts for disseminating critical insights, forging collaborative networks, and accelerating progress in this vital area of healthcare.

Why to Attend:                    

Attending the Drug Formulation Bioavailability 2024 conference offers numerous benefits for professionals, researchers, and experts. These include opportunities for knowledge expansion, networking opportunities, professional development, stay updated, visibility and recognition, business opportunities, contribution to the field. Attending the Drug Formulation Bioavailability 2024 conference offers a valuable opportunity to learn, connect, and contribute to the advancement of drug formulation and bioavailability, ultimately benefiting both your career and the broader pharmaceutical community.

Sessions and Tracks

Track 01: Advanced Drug Delivery Systems

Advanced Drug Delivery Systems will explore cutting-edge advancements in drug delivery systems designed to enhance therapeutic efficacy, improve patient compliance, and minimize side effects. Presentations will cover innovative technologies, novel materials, and emerging strategies in the field of drug delivery.

Methods of Advanced Drug Delivery Systems:

• Nanotechnology-Based Drug Delivery Systems
• Targeted Drug Delivery Approaches
• Implantable and Injectable Drug Delivery Systems
• Oral Drug Delivery Innovations
• Inhaled Drug Delivery Systems
• Hydrogels and Biomaterial-Based Delivery Systems
• Gene and RNA-Based Delivery Systems
• Novel Drug Delivery Systems

Track 02: Formulation Optimization and Design

Formulation design and development encompass the integration of multiple components and the optimization of process parameters. Excipients play a crucial role as essential constituents of high-quality drug products. Therefore, it is imperative to ensure that the development process avoids any potential incompatibilities to maintain product integrity and efficacy.

Drug Formulation Strategies:

• Rational Formulation Design Strategies
• Excipient Selection and Compatibility Studies
• Physicochemical Characterization of Formulations
• Optimization of Drug Delivery Systems
• In Silico Modeling and Computational Approaches

Track 03: Analytical Method Development and Validation

Analytical Method Development and Validation, procedures, and best practices pertaining to the creation and verification of analytical methods for drug analysis are covered in Analytical Method Development and Validation. Presentations will address a range of topics, including as regulatory issues, validation parameters, and method development methodologies.

• High-performance liquid chromatography (HPLC)
• Gas chromatography (GC)
• UV-Visible spectroscopy
• Mass spectrometry (MS)
• Nuclear magnetic resonance (NMR)
• Capillary electrophoresis (CE)
• Artificial Intelligence (AI) in Analytical Chemistry
• Digitalization and Data Analytics

Track 04: Active Pharmaceutical Ingredient (API)

Active Pharmaceutical Ingredients (APIs) stand as the essential constituents of pharmaceutical drugs, responsible for their therapeutic efficacy. They are pivotal across the entirety of drug development, from initial discovery to final distribution. APIs undergo rigorous scrutiny and play integral roles in drug discovery, formulation optimization, regulatory clearance, manufacturing, and quality assurance procedures.

• Drug discovery
• Formulation development
• Regulatory approval
• Manufacturing
• Quality control

Track 05: Biopharmaceutical Considerations in Formulation

Biopharmaceutical considerations in formulation refer to the assessment and incorporation of factors related to the drug's behavior within the biological environment. These considerations are crucial for designing pharmaceutical formulations that optimize drug delivery, absorption, distribution, metabolism, and excretion in the body.

Key aspects of biopharmaceutical considerations include:

• Route of Administration
• Drug Solubility
• Permeability
• Stability
• Bioavailability & Bioequivalence

Track 06: Quality Control and Assurance in Drug Manufacturing

This will delve into the critical aspects of ensuring quality control and assurance throughout the drug manufacturing process. Presentations will cover key principles, methodologies, and regulatory requirements aimed at maintaining product quality, safety, and efficacy.

Principles of Quality Control and Assurance:

• Regulatory Framework and Compliance
• Quality Management Systems
• Analytical Techniques in Quality Control
• Process Validation and Monitoring
• Risk Management in Quality Assurance

Track 07: Drug Stability Studies and Shelf-Life Determination

Drug stability studies are conducted to assess the chemical, physical, and microbiological stability of pharmaceutical products over time. These studies aim to evaluate how various factors such as temperature, humidity, light, and packaging affect the quality and integrity of drugs. Shelf-life determination involves calculating the period during which a pharmaceutical product remains stable and maintains its desired quality attributes under recommended storage conditions. The shelf life is typically expressed as an expiration date on the product label and represents the time until the product is expected to exceed predefined acceptance criteria for potency, purity, and performance.

Key aspects of Stability Testing:

• Regulatory Guidelines and Requirements
• Stability Study Design and Protocols
• Analytical Methods for Stability Testing
• Stability Testing of Drug Substances and Products
• Evaluation of Stability Results
• Shelf-Life Determination and Labeling
• Case Studies and Practical Considerations

Track 08: Novel Excipients and Drug Delivery Platforms

Novel excipients and drug delivery platforms refer to innovative components and systems used in pharmaceutical formulations to improve drug delivery, efficacy, and patient outcomes. Excipients are inactive ingredients added to pharmaceutical formulations alongside the active pharmaceutical ingredient (API). Novel excipients encompass newly developed or recently discovered substances that offer unique properties and functionalities in drug delivery systems. Drug delivery platforms are specialized systems or technologies designed to deliver therapeutic agents to specific sites in the body, control drug release kinetics, and improve drug bioavailability.

Key aspects of Novel Excipients and Drug Delivery Platforms:

• Innovative Excipients for Solubility Enhancement
• Biodegradable and Biocompatible Polymers
• Nanotechnology-Based Drug Delivery Systems
• Advanced Lipid-Based Formulations
• Hydrogels and Mucoadhesive Systems
• 3D Printing in Pharmaceutical Manufacturing
• Smart Drug Delivery Devices and Implants

Track 09: Bioavailability & Bioequivalence Enhancement Strategies

Bioavailability and bioequivalence enhancement strategies aim to improve the absorption, distribution, metabolism, and excretion (ADME) of pharmaceutical compounds, thereby enhancing their therapeutic effectiveness and ensuring consistent clinical performance.

Here's an outline of key strategies in this domain:

• Solubility Enhancement
• Permeability Enhancement
• Controlled Release Formulations
• Drug Delivery Systems
• Prodrug Approaches
• Pharmacokinetic Modulation
• Bioequivalence Enhancement
• Co-administration and Combination Therapy

Track 10: Regulatory Considerations and Compliance

Regulatory considerations and compliance are fundamental aspects of pharmaceutical development and manufacturing, ensuring that drugs meet stringent quality, safety, and efficacy standards set by regulatory agencies worldwide.

Here's an overview of key considerations and compliance requirements:

• Good Manufacturing & Laboratory& Clinical Practices
• Pharmaceutical Quality Systems (PQS)
• Drug Registration and Approval
• Pharmacovigilance and Post-Marketing Surveillance
• Labeling and Packaging Requirements
• Product Quality and Stability Testing

Track 11: Case Studies and Clinical Applications

This will explore real-world case studies and clinical applications of pharmaceutical drugs, highlighting their therapeutic efficacy, safety profiles, and practical considerations in clinical practice. Presentations will cover diverse therapeutic areas, drug classes, and patient populations to provide insights into evidence-based pharmacotherapy and clinical decision-making.

Case Studies & Applications of Drug:

• Cardiovascular Pharmacotherapy
• Psychopharmacology
• Pain Management
• Infectious Diseases
• Oncology Pharmacotherapy
• Diabetes Management
• Immunosuppression and Autoimmune Disorders
• Geriatric Pharmacotherapy

Track 12: Green Chemistry in Drug Formulation

Green chemistry in drug formulation refers to the application of environmentally sustainable principles and practices throughout the process of developing pharmaceutical products. This approach aims to minimize the environmental impact of drug manufacturing processes, reduce waste generation, and improve the overall sustainability of pharmaceutical production.

Key aspects of green chemistry in drug formulation include:

• Reducing Hazardous Substances
• Maximizing Atom Economy
• Minimizing Energy Consumption
• Utilizing Renewable Feedstocks
• Improving Process Efficiency
• Designing Biodegradable Formulations
• Implementing Green Analytical Techniques